Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)-Reference-Cited by-同舟云学术

Acceptable intakes (AIs) for 11 small molecule N-nitrosamines (NAs)

Published:2023-08 Issue: Volume:142 Page:105415
ISSN:0273-2300
Container-title:Regulatory Toxicology and Pharmacology
language:en
Short-container-title:Regulatory Toxicology and Pharmacology

Author:

Bercu Joel P.,Masuda-Herrera Melisa,Trejo-Martin Alejandra,Sura Priyanka,Jolly Robert,Kenyon Michelle,Thomas Rob,Ponting David J.,Snodin David,Tuschl Gregor,Simon Stephanie,De Vlieger Kathleen,Hutchinson Richard,Czich Andreas,Glowienke Susanne,Reddy M. Vijayaraj,Johanssen Sandra,Vock Esther,Claude Nancy,Weaver Richard J.

Publisher

Elsevier BV

Subject

Toxicology,General Medicine

Reference57 articles.

1. Validation study of the combined repeated-dose toxicity and genotoxicity assay using gpt delta rats;Akagi;Cancer Sci.,2015

2. Induction of bladder tumours in mice with dibutylnitrosamine;Bertram;Br. J. Cancer,1970

3. Thesis - Dose-Response Relationships in Nitrosamine Carcinogenesis;Brantom,1983

4. Developing structure-activity relationships for N-nitrosamine activity;Cross;Comput Toxicol,2021

5. Practical and science-based strategy for establishing acceptable intakes for drug product N-nitrosamine impurities;Dobo;Chem. Res. Toxicol.,2022

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. N-nitrosamine impurity risk assessment in pharmaceuticals: Utilizing In vivo mutation relative potency comparison to establish an acceptable intake for NTTP;Regulatory Toxicology and Pharmacology;2024-09

2. Solid-phase extraction followed by gas chromatography-mass spectrometry for the quantitative analysis of small molecule N-nitrosamine impurities in antitussive syrups;Journal of Chromatography A;2024-09

3. Estimation of acceptable daily intake values based on modeling and in vivo mutagenicity of NDSRIs of fluoxetine, duloxetine and atomoxetine;Regulatory Toxicology and Pharmacology;2024-09

4. Risk Assessment and Control of N-Nitrosamines in Antibody–Drug Conjugates: Current Industry Practices;Organic Process Research & Development;2024-07-30

5. Quantum chemical calculations of nitrosamine activation and deactivation pathways for carcinogenicity risk assessment;Frontiers in Pharmacology;2024-07-17